TETRALOGIC PHARMACEUTICALS CORP Common Stock
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch TLOG and buy or sell other stocks, ETFs, and their options commission-free!About TLOG
TetraLogic Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel small molecule therapeutics in oncology and infectious diseases. Its products include Birinapant and SHAPE.
CEOJ. Kevin Buchi, MBA, CPA
CEOJ. Kevin Buchi, MBA, CPA
Employees11
Employees11
HeadquartersMalvern, Pennsylvania
HeadquartersMalvern, Pennsylvania
Founded2001
Founded2001
Employees11
Employees11
TLOG Key Statistics
Market cap2.45K
Market cap2.45K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume3.34K
Average volume3.34K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.001
52 Week high$0.001
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
With a market cap of 2.45K, TETRALOGIC PHARMACEUTICALS CORP Common Stock(TLOG) trades at $0.00.
On 2025-12-08, TETRALOGIC PHARMACEUTICALS CORP Common Stock(TLOG) stock opened at —, reached a high of —, and a low of —.
The TETRALOGIC PHARMACEUTICALS CORP Common Stock(TLOG)'s current trading volume is 0, compared to an average daily volume of 3.34K.
In the last year, TETRALOGIC PHARMACEUTICALS CORP Common Stock(TLOG) shares hit a 52-week high of $0.00 and a 52-week low of $0.00.
In the last year, TETRALOGIC PHARMACEUTICALS CORP Common Stock(TLOG) shares hit a 52-week high of $0.00 and a 52-week low of $0.00.